Enhancing cancer clinical trial management: Recommendations from a qualitative study of trial participants' experiences

Psycho-Oncology

Volumn 9, Issue 4, 2000, Pages 314-322

  Bultz, Barry D ^a,b   Speca, Michael ^a   Brasher, Penny M ^c   Geggie, Peter H S ^a   Page, Stacey A ^b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Alberta Cancer Board   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER; CANCER RESEARCH; CLINICAL TRIAL; DECISION MAKING; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HEALTH EDUCATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PSYCHOLOGIC TEST; QUALITATIVE DIAGNOSIS; QUALITY OF LIFE; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ATTITUDE TO HEALTH; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DECISION MAKING; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEOPLASMS; NURSING METHODOLOGY RESEARCH; PATIENT EDUCATION; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL SUPPORT;

EID: 0033845134     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1611(200007/08)9:4<314::AID-PON464>3.0.CO;2-C     Document Type: Article

References (38)

1. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international trials in oncology
2. Quality of life assessment in a phase I study
3. Faith healing hope and the FDA: The politics of AIDS drug trials
4. New approach for recruitment into randomised controlled trials
5. Developing clinical trial protocols: The use of patient focus groups
6. Attitudes towards clinical trials among patients and the public
7. Researching research: Patients' experiences of participation in phase I and II anti-cancer drug trials
8. Ethical and practical problems of early anti-cancer drug trials: A review of the literature
9. Perceptions of cancer patients and their physicians involved in phase I trials
10. Responses and toxic deaths in phase I clinical trials
11. Therapeutic response in phase I trials of anti-neoplastic agents
12. Teaching senior oncologists communication skills: Results from phase I of a comprehensive longitudinal program in the United Kingdom
13. A new readability yardstick
14. Issues in the design of drug trials for AIDS
15. Adherence in AIDS clinical trials: A framework for clinical research and clinical care
16. Patients in phase I trials of anti-cancer agents in Japan: Motivation, comprehension and expectations
17. Hope, consent and clinical research
18. Trust. The fragile foundation of contemporary biomedical research
19. Attributions of control, experienced meaning, and psychosocial well-being in patients with advanced cancer
20. Meaning of illness for women with breast cancer
21. Clinical drug development: An analysis of phase II trials, 1970-1985
22. The impact of phase I clinical trials on the quality of life of patients with cancer
23. Quality of life endpoints in cancer clinical trials: Review and recommendations
24. The epidemiological and economic consequences of AIDS clinical trials
25. Informed consent for investigational chemotherapy. Patients' and physicians' perspectives
26. Patient motivation and informed consent in a phase I study of an anti-cancer agent
27. The awareness contexts and the construction of dying in the cancer treatment setting: Micro and macro levels in narrative analysis
28. EORTC new drug development office co-ordinating and monitoring programme for phase I and II trials with new anti-cancer agents
29. Race, gender, drug use and participation in AIDS clinical trials. Lessons from a municipal hospital cohort
30. The dilemmas of randomisation and equipoise from the viewpoint of a patient invited to participate in a breast cancer trial
31. Attributions and adjustment to life-threatening illness
32. The hospital anxiety and depression scale